Targeting RTK signaling pathways in cancer
T Regad - Cancers, 2015 - mdpi.com
The RAS/MAP kinase and the RAS/PI3K/AKT pathways play a key role in the regulation of
proliferation, differentiation and survival. The induction of these pathways depends on …
proliferation, differentiation and survival. The induction of these pathways depends on …
ERK5: structure, regulation and function
GN Nithianandarajah-Jones, B Wilm, CEP Goldring… - Cellular signalling, 2012 - Elsevier
Extracellular signal-regulated kinase 5 (ERK5), also termed big mitogen-activated protein
kinase-1 (BMK1), is the most recently identified member of the mitogen-activated protein …
kinase-1 (BMK1), is the most recently identified member of the mitogen-activated protein …
The MEK5/ERK5 pathway in health and disease
R Paudel, L Fusi, M Schmidt - International Journal of Molecular Sciences, 2021 - mdpi.com
The MEK5/ERK5 mitogen-activated protein kinases (MAPK) cascade is a unique signaling
module activated by both mitogens and stress stimuli, including cytokines, fluid shear stress …
module activated by both mitogens and stress stimuli, including cytokines, fluid shear stress …
Cell-specific translational profiling in acute kidney injury
J Liu, AM Krautzberger, SH Sui… - The Journal of …, 2014 - Am Soc Clin Investig
Acute kidney injury (AKI) promotes an abrupt loss of kidney function that results in
substantial morbidity and mortality. Considerable effort has gone toward identification of …
substantial morbidity and mortality. Considerable effort has gone toward identification of …
OXTRHigh stroma fibroblasts control the invasion pattern of oral squamous cell carcinoma via ERK5 signaling
L Ding, Y Fu, N Zhu, M Zhao, Z Ding, X Zhang… - Nature …, 2022 - nature.com
Abstract The Pattern Of Invasion (POI) of tumor cells into adjacent normal tissues clinically
predicts postoperative tumor metastasis/recurrence of early oral squamous cell carcinoma …
predicts postoperative tumor metastasis/recurrence of early oral squamous cell carcinoma …
Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms
Y Wang, R Luo, X Zhang, H Xiang, B Yang… - Nature …, 2023 - nature.com
Diffuse gliomas are devastating brain tumors. Here, we perform a proteogenomic profiling of
213 retrospectively collected glioma tumors. Proteogenomic analysis reveals the …
213 retrospectively collected glioma tumors. Proteogenomic analysis reveals the …
Carbon monoxide: mechanisms of action and potential clinical implications
L Rochette, Y Cottin, M Zeller, C Vergely - Pharmacology & therapeutics, 2013 - Elsevier
Small amounts of carbon monoxide (CO) are continuously produced in mammals. The
intracellular levels of CO can increase under stressful conditions following the induction of …
intracellular levels of CO can increase under stressful conditions following the induction of …
The MEK5–ERK5 kinase axis controls lipid metabolism in small-cell lung cancer
S Cristea, GL Coles, D Hornburg, M Gershkovitz… - Cancer Research, 2020 - AACR
Small-cell lung cancer (SCLC) is an aggressive form of lung cancer with dismal survival
rates. While kinases often play key roles driving tumorigenesis, there are strikingly few …
rates. While kinases often play key roles driving tumorigenesis, there are strikingly few …
ERK5 kinase activity is dispensable for cellular immune response and proliferation
ECK Lin, CM Amantea… - Proceedings of the …, 2016 - National Acad Sciences
Unlike other members of the MAPK family, ERK5 contains a large C-terminal domain with
transcriptional activation capability in addition to an N-terminal canonical kinase domain …
transcriptional activation capability in addition to an N-terminal canonical kinase domain …
The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target
AES Simoes, CMP Rodrigues, PM Borralho - Drug discovery today, 2016 - Elsevier
Highlights•The present review highlights the emerging clinical relevance of MEK5/ERK5
signalling as a therapeutic target and prognostic factor in several top-leading diagnosed …
signalling as a therapeutic target and prognostic factor in several top-leading diagnosed …